¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"reverse electron transport"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • reverse transcriptase polymerase chain reaction
    ¿ªÀü»çÈ¿¼ÒÁßÇÕÈ¿¼Ò¿¬¼â¹ÝÀÀ
  • reverse transcription
    ¿ªÀü»ç
  • reverse Waters position
    ¿ª¿öÅͽºÀÚ¼¼
  • electron
    ÀüÀÚ
  • electron affinity
    ÀüÀÚģȭ·Â
  • electron beam
    ÀüÀÚ¼±, ÀüÀÚºö
  • electron capture
    ÀüÀÚÆ÷ȹ
  • electron carrier
    ÀüÀÚ¿î¹Ýü
  • electron configuration
    ÀüÀÚ¹èÄ¡
  • electron density
    ÀüÀڹеµ
  • electron diffraction
    ÀüÀÚȸÀý
  • electron emission
    ÀüÀÚ¹æÃâ
  • electron interrupter
    ÀüÀÚÂ÷´Ü±â
  • electron microscope
    ÀüÀÚÇö¹Ì°æ
  • electron microscopic autoradiography
    ÀüÀÚÇö¹Ì°æÀÚ°¡Á¶Á÷¹æ»ç¼±ÃÔ¿µ(¼ú)
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • facilitated transport
    ÃËÁø¿î¹Ý
  • transport host
    ¿î¹Ý¼÷ÁÖ
  • maximum transport
    ÃÖ´ë¿î¹ÝÄ¡, ÃÖ´ëÀ̵¿Ä¡
  • maximum tubular transport
    ÃÖ°í¿ä¼¼°üÀ̵¿Ä¡
  • membrane transport
    ¸·¿î¹Ý
  • transport medium
    ¿î¹Ý¹èÁö
  • net transport
    ¼ø¿î¹Ý
  • transport number
    À̵¿ºÐÀ²
  • passive transport
    ¼öµ¿¿î¹Ý
  • supersonic transport
    ÃÊÀ½ÆÄ¼ö¼Û
  • transport
    ¿î¹Ý
  • transcapillary transport
    ¸ð¼¼°ü¿î¹Ý
  • transmembrane transport
    ¸·¿î¹Ý
  • electron affinity
    ÀüÀÚģȭ·Â
  • electron microscopic autoradiography
    ÀüÀÚÇö¹Ì°æÀÚ°¡¹æ»ç¼±¼ú
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • reverse passive hemagglutination=RPHA
    ¿ª¼öµ¿Ç÷±¸ÀÀÁý¹ý
  • reverse phase liquid chromatography
    ¿ª»ó¾×üũ·Î¸¶Åä±×·¡ÇÇ
  • reverse piezoelectric effect
    ¿ª ¾ÐÀüÈ¿°ú
  • reverse transcriptase
    ¿ªÀü»ç È¿¼Ò
  • reverse transcriptase
    ¿ªÀüÆ®·£½ºÅ©¸³Å×ÀÌÁî
  • reverse transcriptase
    ¿ªÀü»çÈ¿¼Ò
  • reverse transcription
    ¿ªÀü»ç
  • reverse transcription
    ¿ªÀü»ç(æ½ï®ÞÐ).
  • spiral reverse bandage
    ³ª¼±¿ªÇàºØ´ë(¡­¿ªÇàºØ´ë).
  • transcriptase, reverse
    ¿ªÀü»çÈ¿¼Ò
  • active transport
    ´Éµ¿(Àû)¿î¹Ý(¡­îÜê¡Úæ), ´Éµ¿(Àû)¼ö¼Û(ÒöÔÑîÜâÃáê)
  • carbon dioxide transport
    ÀÌ»êȭź¼Ò ¿î¹Ý(ê¡Úæ)(À̵¿,¼ö¼Û)
  • carrier mediated transport
    ¿î¹Ýü¸Å°³ À̵¿
  • catalysed transport
    Ã˸żö¼Û.
  • co-transport = symport
    °øµ¿¿î¹Ý(À̵¿, ¼ö¼Û)(ÍìÔÒê¡Úæ)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • cotranslational transport
    ¹ø¿ªµ¿½Ã¼ö¼Û(Ûèæ»ÔÒãÁâÃáê)
  • coupled transport
    "°ø¿ª¼ö¼Û(ÍëæµâÃáê), ¦Áø¼ö¼Û"
  • fractional electrical transport
    ºÐº° Àü±â ¼ö¼Û(ÝÂܬï³Ñ¨âÃáê)
  • gradient-coupled active transport
    ±¸¹è(ÎþÛÕ) ¦Áø ´Éµ¿¼ö¼Û(ÒöÔÑâÃáê)
  • homocellular transport
    µ¿Áú¼¼Æ÷ ¼ö¼Û(ÔÒòõá¬øàâÃáê)
  • hydrogen transport system
    ¼ö¼Ò ¼ö¼Û(â©áÈâÃáê) ½Ã½ºÅÛ
  • illicit transport
    ¹Ð¼ö¼Û(ÚËâÃáê)
  • intracellular transport
    ¼¼Æ÷³» ¼ö¼Û(á¬øàÒ®âÃáê)
  • mediated transport
    ¸Å°³¼ö¼Û(ØÚË¿âÃáê)
  • membrane transport
    ¸·À̵¿(دì¹ÔÑ)
  • nonmediated transport
    ºñ(Þª)¸Å°³ ¼ö¼Û(ØÚË¿âÃáê)
  • oxygen transport
    »ê¼Ò¿î¹Ý(ß«áÈê¡Úæ)
  • passive mediated transport
    ¼öµ¿ ¸Å°³¿î¹Ý(áôÔÑØÚË¿ê¡Úæ)
  • passive transport
    ¼öµ¿ ¼ö¼Û(áôÔÑâÃáê)
  • post-translational transport
    ¹ø¿ªÈÄ ¿î¹Ý(ê¡Úæ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • recoil electron
    ¹ÝµµÀüÀÚ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
EI Edmonton injector; electrolyte imbalance; electron impact; electron ionization; emotionally impaired...
E/M electron microscope, electron microscopy; evaluation and management
rT3 reverse T3
HMRTE human milk reverse transcriptase enzyme
HRTE human reverse transcriptase enzyme
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
HAChT High affinity choline transport
IFT Intraflagellar transport
MCT Mucociliary transport
NTF2 Nuclear transport factor 2
PST Phosphate Specific Transport
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • oxygen transport mechanism
    »ê¼Ò ¿î¹Ý ±âÀü
  • passive transport
    Çǵ¿Àû ¿î¹Ý, Çǵ¿Àû À̵¿, ¼öµ¿Àû À̵¿
  • sodium transport system
    ³ªÆ®·ý ¿î¹Ý°è
  • transport
    ¼ö¼Û, ¿î¼Û
    »ý¹°°è¿¡ ÀÖ´Â ¹°ÁúÀÇ À̵¿À¸·Î¼­, ƯÈ÷ ¼¼Æ÷ÀÇ ³»¿Ü³ª »óÇÇÃþÀ» ÅëÇØ¼­ À̵¿ÇÏ´Â °Í.
  • transport oxygen
    »ê¼Ò ¿î¹Ý
  • virus transport medium
    ¹ÙÀÌ·¯½º ¿î¼Û ¹èÁö
  • electron
    ÀüÀÚ
    À½ Àü±âÀÇ ÃÖ¼Ò ´ÜÀ§ ¶Ç´Â ÀÚ±â ÀÔÀÚ. Àý´ë Á¤Àü±â ´ÜÀ§. 4.77*10-10 ¶Ç´Â Àý´ë ÀüÀڱ⠴ÜÀ§ 1.59*10-20 ¿¡ »ó´çÇϸç, ±×ÀÇ Áú·®Àº Àû´çÇÑ ¼Óµµ·Î À̵¿Çϰí ÀÖÀ» ¶§¿¡ ¼ö¼Ò ¿øÀÚÀÇ 1/1845, Áï 9*10-28 ±×·¥ÀÌ´Ù. µµÃ¼ Áß¿¡ È帣´Â ÀüÀÚ´Â Àü·ù·Î¼­, ¹æ»ç¼± ¹°Áú·ÎºÎÅÍ´Â ¥â¼±À¸·Î ¹æÃâµÇ¾î ¿øÀÚÇÙ ÁÖÀ§ÀÇ ±Ëµµ¸¦ ȸÀüÇÏ¿© ±× ¿øÀÚÀÇ Áú·®°ú ¹æ»ç´É ÀÌ¿ÜÀÇ ÀÌÈ­ÇÐÀû ¼º»óÀ» Á¿ìÇÑ´Ù.
  • electron affinity
    ÀüÀÚ Ä£È­·Â
    ¿øÀÚ°¡ ÀüÀÚ 1°³¿Í °áÇÕÇÒ ¶§¿¡ ¹æÃâÇÏ´Â ¿¡³ÊÁö.
  • electron bath
    ÀüÇØÁ¶
  • electron beam microporbe analysis
    ÀüÀÚ±¤ ¹Ì¼¼ Žħ ¿ä¼Ò ºÐ¼®, ÀüÀÚ±¤ ¹Ì¼¼ Žħ ºÐ¼®
  • electron beam therapy
    ÀüÀÚ¼± Ä¡·á
  • electron carrier
    ÀüÀÚ ¿î¹Ýü
  • electron configuration
    ÀüÀÚ ¹èÄ¡
  • electron density
    ÀüÀÚ ¹Ðµµ
    ÀüÀÚÇö¹Ì°æ¿¡¼­ ÀüÀÚÀÇ Åõ°ú¸¦ ¸·À» ¼ö ÀÖ´Â µÎ²² ¶Ç´Â ¹Ðµµ.
  • electron emission
    ÀüÀÚ ¹æÃâ
    ¿øÀÚ¿¡ ¹æ»ç´ÉÀ» ÁÖ´Â ÀüÀÚÀÇ Çϳª.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
reverse transcriptase <enzyme> RNA directed DNA polymerase.
Enzyme first discovered in retroviruses, that can construct double stranded DNA molecules from the single stranded RNA templates of their genomes. Reverse transcription now appears also to be involved in movement of certain mobile genetic elements, such as the Ty plasmid in yeast, in the replication of other viruses such as Hepatitis B and possibly in the generation of mammalian pseudogenes.
(18 Nov 1997)
reverse transcriptase inhibitors Inhibitors of reverse transcriptase (RNA-directed DNA polymerase), an enzyme that synthesises DNA on an RNA template.
(12 Dec 1998)
reverse transcriptase md <molecular biology> A viral enzyme that constructs DNA from an RNA template, which is an essential step in the life-cycle of a retrovirus such as HIV
(09 Oct 1997)
reverse transcriptase PCR A technique used to amplify RNA targets. The specimen containing the target RNA (e.g., HIV-1 RNA, Hepatitis C Virus RNA) is subjected to reverse transcription to make complementary DNA (cDNA), which is then, in turn, amplified by PCR.
Acronym: RT-PCR
(05 Mar 2000)
reverse transcription <molecular biology> The process of copying information found in RNA into DNA.
(09 Oct 1997)
reverse transcriptons An enzyme that converts RNA to DNA. Some viruses have only RNA as their primary genetic material. By converting their RNA genes to DNA with this enzyme, the host cell is 'tricked' into creating new copies of the virus. Useful in genetic engineering to make DNA from mRNA.
(14 Nov 1997)
reverse Trendelenburg position Supine position without flexing or extending, in which the head is higher than the feet.
(05 Mar 2000)
HIV-1 reverse transcriptase <enzyme> HIV-1 enzyme responsible for the synthesis of DNA from genomic RNA of the virus. It is encoded by the pol gene of HIV-1.
Registry number: EC 2.7.7.-
(12 Dec 1998)
HIV-2 reverse transcriptase <enzyme> Responsible for synthesis of double-stranded DNA from the genomic RNA of the virus; has rnase h and DNA-dependent DNA polymerase activities; was indexed as reverse transcriptase (87-91)
Registry number: EC 2.7.7.-
(26 Jun 1999)
DNA reverse gyrase <enzyme> A topoisomerase II subclass which introduces positive superhelical turns into DNA
Registry number: EC 3.1.-
Synonym: reverse gyrase
(26 Jun 1999)
triiodothyronine, reverse <chemical> 0-(4-hydroxy-3,5-diiodophenyl)-3-iodo-l-tyrosine. A metabolite of thyroxine formed by the peripheral degradation of thyroxine as a result of the tyrosyl or inner ring 5-deiodination. In systemic disease states or in neonates, levels of triiodothyronine are low and those of reverse triiodothyronine are elevated. Reverse t3 is therefore useful as a diagnostic aid and in the treatment of foetal and infantile hypothyroidism.
Chemical name: L-Tyrosine, O-(4-hydroxy-3,5-diiodophenyl)-3-iodo-
(12 Dec 1998)
active transport <biochemistry, chemistry> Transport of ions, nutrients or other molecules into a cell against a concentration gradient, this requires the expenditure of energy through ATP hydrolysis.
(06 May 1997)
anterograde transport Movement of material from the cell body of a neuron into axons and dendrites retrograde axoplasmic transport also occurs).
(18 Nov 1997)
atrial transport function The role of the atria in filling and stretching the ventricles by their presystolic contraction, without which the force of ventricular contraction and hence the cardiac output may significantly decrease.
(05 Mar 2000)
axonal transport Directed transport of organelles and molecules along a nerve cell axon. Transport can be anterograde (from the cell body) or retrograde (toward the cell body). (alberts et al., molecular biology of the cell, 3d ed, pg3)
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • reverse angle
    ¿ª°¢µµ(Ä«¸Þ¶ó À§Ä¡¸¦ ¹Ù²Ù¾î ÁÖ¿ä ÇÇ»çüÀÇ µÚ·Î µ¹¾Æ ´ë¸éÇϰí ÀÖ´Â ¸®Æ÷Å͸¦ ºñÄ¡´Â ¹æ¹ý)
  • reverse commuting
    ¿ª¹æÇâ Åë±Ù(µµ½Ã¿¡¼­ ±³¿Ü·Î)
  • reverse culture shock
    ¿ª¹®È­ ¼îÅ©(¿Ü±¹¿¡¼­ ¿À·§µ¿¾È »ýȰÇÑ »ç¶÷ÀÌ °í±¹À¸·Î µ¹¾Æ¿ÔÀ» ¶§ ´À³¢´Â ¼Ò¿Ü°¨)
  • reverse discrimination
    ¿ªÂ÷º°(ÇÇÂ÷º°ÀÚ ¿ì´ë·Î »ý±â´Â ±×¹ÛÀÇ »ç¶÷ÀÇ ºÒ¸®)
  • reverse engineering
    ºÐÇØ °øÇÐ;¿ª¼³°è(½ÅÁ¦Ç°À» ¼³°èÇÏ¿© ±¸Á¶¸¦ Á¤¹ÐÇÏ°Ô ºÐ¼®.±× ¼³°è¸¦ ¿ªÀ¸·Î ŽÁöÇÏ´Â ±â¼ú)
  • reverse gear
    (ÀÚµ¿Â÷ÀÇ)ÈÄÁø ±â¾î
  • reverse racism
    ¿ªÀÎÁ¾ Â÷º°(ÈæÀÎ.¼Ò¼ö ¹ÎÁ·ÀÇ Â÷º°ÆóÁö ¶§¹®¿¡ ¹éÀÎÀÌ ÀÔÇÐ.Ãë¾÷¿¡¼­ ¿ÀÈ÷·Á ºÒ¸®ÇØ Áö´Â »óÅÂ)
  • reverse transcriptase
    ¿ªÀü»çÈ¿¼Ò(RNA¿¡ ÀÇÁ¸ÇÏ¿© DNA¸¦ ÇÕ¼º½ÃŰ´Â È¿¼Ò)
  • reverse-charge
    (ÅëÈ­¿ä±ÝÀÌ)¼ö½ÅÀÎ ÁöºÒÀÇ
  • reverse-engineered
    ºÐÇØÇÏ¿© ¸ð¹æÇÑ(¹ÝµµÃ¼¿¡ ´ëÇÏ¿© ÈçÈ÷ ¾¸)
  • electron
    ÀüÀÚ
  • electron
    ÀüÀÚ
  • electron affinity
    (¹°)ÀüÀÚ Ä£È­·Â
  • electron beam
    (¹°)ÀüÀÚ ºö(Àü°è,ÀÚ°è¿¡¼­ ÇÑ ¹æÇâÀ¸·Î ¸ð¾ÆÁ® È帣´Â ÀüÀÚÀÇ È帧)
  • electron beam melting
    (±Ý¼Ó)ÀüÀÚºö ¿ëÇØ¹ý Àå
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á